Go directly to content Go directly to font size and contrast

Project Details

Person

Print View

Professorin Dr. Juliane Walz

Address Universitätsklinikum Tübingen
Abteilung für Peptid-basierte Immuntherapie
Otfried-Müller-Straße 10
72076 Tübingen

Projects

As Applicant
- Current projects
  - The soluble HLA immunopeptidome as active modulator and biomarker for T cell immunity in SARS-CoV-2 infection and COVID-19 (Research Grants)
  - iVAC-HNSCC01: Two-arm, placebo-controlled, double-blinded, randomized Phase II study to evaluate efficacy and safety of personalized multi-peptide vaccination in combination with Pembrolizumab in patients with unresectable recurrent, or metastatic head and neck squamous cell carcinoma (Clinical Trials)
- Completed projects
  - HLA ligandome analysis of Multiple Myeloma - Novel myeloma-associated antigens for peptide-based immunotherapy (Research Grants)
As Spokesperson
- Current projects
  - EXC 2180: Image-guided and Functionally Instructed Tumor Therapies (iFIT) (Clusters of Excellence (ExStra))
As Participating Researcher
- Current projects
  - EXC 2124: Controlling Microbes to Fight Infections (CMFI) (Clusters of Excellence (ExStra))
As Co-Investigator
- Current projects
  - Medical Innovation through Interdisciplinarity Clinician Scientist (MINT-CS) program (Research Grants)

© 2026 DFG Disclaimer / Copyright / Privacy Policy